pm012
Botanicalexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2012 (NCT01715350)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pm012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05811000 | Phase 2/Phase 3 (Phase 3) | Nov 27, 2020 | LSK Global Pharma Services Co. Ltd., Mediforum |
| NCT01715350 | Phase 2 | May 1, 2012 | Archer Daniels Midland Co., Catholic University of Korea, Ilsan Hospital, Kyung Hee University, Purimed Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Archer Daniels Midland Co. | For profit | 1 | 0 | 1 | 2012 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Ilsan Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Kyung Hee University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| LSK Global Pharma Services Co. Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Mediforum | For profit | 1 | 1 | 1 | 2020 |
| Purimed Co., Ltd. | For profit | 1 | 1 | 1 | 2012 |
7 organizations
Page 1 / 1